insights_auto
Outlook: 20.0% bullish·0.0% bearish
Go to analysischevron_right
KROS:NASDAQ
Keros Therapeutics Inc
$11.39
0.00%
(0.00) 1D
Nov 19, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 4 analysts giving stock ratings to KROS in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for KROS in the last 3 months.
Highest
Current $11.39
$20.00 (+75.59%)
Average
$18.00 (+58.03%)
Lowest
$16.00 (+40.47%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Jason Zemansky Bank of America Securities | Hold | Reiterated | $18.00 | +58% | 11/16/2026 |
Yun Zhong Wedbush | Hold | Maintained | $16.00 | +40.5% | 11/09/2026 |
Andres Y. Maldonado H.C. Wainwright | Buy | Reiterated | $20.00 | +75.6% | 11/06/2026 |
Benjamin Burnett Wells Fargo | Buy | Maintained | $18.00 | +58% | 09/02/2026 |
Matt Phipps William Blair | Hold | Maintained | - | - | 08/04/2026 |
Thomas Smith Leerink Partners | Buy | Maintained | $23.00 | +101.9% | 08/04/2026 |
Nicholas Lorusso TD Cowen | Hold | Reiterated | - | - | 08/04/2026 |
Srikripa Devarakonda Truist Financial | Buy | Maintained | - | - | 05/15/2026 |
Andreas Argyrides Oppenheimer | Buy | Maintained | $27.00 | +137.1% | 03/09/2026 |
Unknown Analyst Leerink Partners | Buy | Reiterated | $30.00 | +163.4% | 03/06/2026 |
Tiago Fauth Raymond James | Buy | Maintained | $20.00 | +75.6% | 03/05/2026 |